Resources

Outcomes of a pharmacist intervention on diabetic patients

Problem: how can pharmacists play a greater role with diabetic patients?

Diabetes is a chronic disease that is increasingly prevalent in France and accounts for nearly 10% of health spending. The many complications associated with diabetes contribute substantially to this spending and occur when diabetes is insufficiently controlled. The current therapeutic objective of the treatment is measured by HbA1c levels, which should be <7% as defined by NHANES. In France, 41% of patients have HbA1c levels above 7%, and 15% above 8%. In parallel, many studies highlight adherence as an important success factor on HbA1c control.
In this context, pharmacists are essential actors in patient care, and, due to their expertise, wide presence, and accessibility, they could play a greater role in ensuring medical outcomes.

Read the full Success Story and be inspired for your patient engagement strategy like 80+ cutomers from top20 pharma companies who trusted us.

Choose in the menu.

Share

See also

Scientific communications

A multiple-cohort analysis of the SPUR 6/24 patient-reported adherence tool

Articles

Clinical Ink and Observia: Pioneering Personalized Patient Engagement in Clinical Trials

News

By your side in 2024: Happy Holidays from Observia!

Accès plateformes